Premium
Geron Corp (GERN)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes wit... Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.045 | -3.57142857143 | 1.26 | 1.29 | 1.14 | 10656875 | 1.2071334 | CS |
| 4 | -0.345 | -22.1153846154 | 1.56 | 1.5799 | 1.14 | 13998328 | 1.32404624 | CS |
| 12 | -0.41 | -25.2307692308 | 1.625 | 1.8399 | 1.14 | 16370677 | 1.52536162 | CS |
| 26 | -0.045 | -3.57142857143 | 1.26 | 2.01 | 1.14 | 14434237 | 1.52978221 | CS |
| 52 | -0.325 | -21.1038961039 | 1.54 | 2.01 | 1.04 | 11446496 | 1.45084264 | CS |
| 156 | -2.435 | -66.7123287671 | 3.65 | 5.34 | 1.04 | 10330345 | 2.40254982 | CS |
| 260 | -0.205 | -14.4366197183 | 1.42 | 5.34 | 0.9899 | 8030381 | 2.34627371 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
